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Abstract: Medulloblastoma is a highly malignant central nervous system (CNS) tumor 
that arises from the cerebellum. It is the most common primary malignant intracranial 
childhood neoplasm. In adults, medulloblastoma are much less common, accounting for 
< 1% of all adult brain tumors. Herein, author has described a rare case of cerebellar 
medulloblastoma in adult. 
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Introduction 
Medulloblastoma is the most common 
CNS tumor of childhood, accounting for 15% 
to 30% of all childhood brain tumors, and 30% 
to 40% of all posterior fossa tumors. (1) In 
adults, the tumor is much less common, 
accounting for approximately 1% of adult 
primary brain tumors, 80% of which occur 
before the end of the fourth decade. (2) The 
adult tumor is said to occur more often in the 
cerebellar hemispheres than the vermis and is 
more often desmoplastic in histology. The 
exact etiology of medulloblastomas is not 
known. Herein, author has described a rare 
case of cerebellar medulloblastoma in adult. 
Case report 
A 45 years old male presented in 
neurosurgery department with headache and 
gait disturbance for last three months. 
Neurological examination revealed cerebellar 
signs with ataxic gait.  
Magnetic resonance imaging (MRI) of 
brain showed heterogeneous intensity mass 
lesion in posterior fossa mainly involving 
midline (figures 1 and 2).  In view of symptoms 
patient was taken up for surgery.  
Gross total excision of the tumour was 
done via midline suboccipital craniectomy. 
Intraoperatively tumour was greyish white, 
mainly present in midline involving vermis 
and extending into the right cerebellum 
(figure 3). Tumour was sent for 
histopathological examination which revealed 
medulloblastoma desmoplastic variety. After 
the surgery, the patient was alert, his 
neurological examination showed only mild 
truncal ataxia. No obvious mass lesion was 
present in postoperative imaging of brain 
(figure 4). To rule out drop metastasis, MRI 
whole spine was done which was essentially 
normal (figure 5). After suture removal patient 
was sent for radiotherapy and no recurrence 
was found in 6 months of follow up. 
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Figure 1 - Post contrast MRI brain axial section showing heterogeneous intensity mass lesion in posterior fossa 
mainly involving midline 
 
 
Figure 2 - Post contrast MRI brain sagittal section showing midline cerebellar mass 
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Figure 3 - Intra operative image showing greyish white mass, mainly present in midline involving vermis and 
extending into the right cerebellum 
 
Figure 4 - Postoperative image showing no obvious mass lesion 
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Figure 5 - MRI whole spine showing no drop 
metastasis 
Discussion 
Medulloblastoma is a highly malignant 
CNS tumor that arises from the cerebellum. It 
is the most common primary malignant 
intracranial childhood neoplasm, accounting 
for 25% of all childhood tumors. (1) More than 
80% of medulloblastomas are diagnosed in 
children during the first 15 years of life, the 
median age at diagnosis being 5 years. In 
adults (patients ≥ 16 years of age), 
medulloblastomas are much less common, 
accounting for < 1% of all adult brain tumors. 
The incidence of adult medulloblastomas is 
approximately 0.5 per million per year, and 
decreases with increasing age. The exact 
etiology of medulloblastomas is not known. 
(2) 
Medulloblastoma is thought to arise from a 
primitive cell in the external granular layer of 
the cerebellum, but the specific cell of origin 
has not been identified. Pathologically 
medulloblastomas consist of small round blue 
cells. It has two variants - classical and 
desmoplastic. The latter variant has large 
amounts of reticulin and collagen.3 
Medulloblastoma is  located in posterior fossa 
thus it often produces hydrocephalus and 
symptoms of increased ICP, as well as 
cerebellar signs (eg, truncal and limb ataxia, 
nystagmus) (4) which was present in our case. 
Disease may exist as nodular lesions 
outside the primary site anywhere within the 
neuraxis, including the spine and 
supratentorial cerebrum, and may involve the 
CSF.4 In our case there was no drop metastasis 
in spine. 
Magnetic resonance imaging (MRI) brain 
is the investigation of choice. Lesions are 
usually ISO to hypointense on T1WI, have 
variable signal on T2WI, and frequently 
demonstrate contrast enhancement. These 
tumors tend to be homogenous in appearance, 
with occasional cystic or necrotic areas. (5) 
Surgery is the treatment of choice. The goal of 
surgery is to remove all visible tumour. 
Survival of adult medulloblastoma patients 
may be influenced by the extent of residual 
disease following surgery, particularly for 
patients without evidence of dissemination.  
Treatment of associated hydrocephalus can 
be managed by external drainage with tumor 
decompression, tumor decompression alone, 
or by the use of various shunting procedures. 
(6) In our case gross total excision of tumour 
was done. 
Craniospinal axis radiation therapy is the 
standard of care for the treatment of adult 
medulloblastoma patients, as 
medulloblastomas are quite radiosensitive. 
Standard radiation doses to the craniospinal 
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axis involve delivering 35 to 45 Gy to the brain 
and 30 to 40 Gy to the spine, with a dose of 54 
Gy to the primary tumor site. (6) In contrast to 
childhood medulloblastoma, the role of 
chemotherapy in adult medulloblastoma 
patients is undetermined. Prados and 
colleagues found that those patients who 
received adjuvant chemotherapy (mostly 
nitrosourea-based regimens) had a statistically 
significantly longer survival as compared to 
those who did not receive adjuvant 
chemotherapy. (7) In our case, patient was 
received craniospinal irradiation. 
The recurrence rate for medulloblastomas 
in adults is approximately 50% to 60%. The 
median survival after recurrence has been 
reported to be approximately 1.3 years. The 
most common site of recurrence is the 
posterior fossa. Other sites of recurrence 
include the spine, CSF, supratentorial 
cerebrum, bone, and other extraneural sites. 
(8) In our case recurrence was not found after 
6 month of follow up. 
Conclusion 
Adult variety of medulloblastomas have 
notable differences as compared to the 
pediatric type. There is higher frequency of 
lateral cerebellar location, desmoplastic 
histology, and late recurrences in the adult 
variety. The 5-year overall survival rates are 
comparable between the adult and pediatric 
population.The management of adult 
medulloblastoma patients involves a thorough 
staging work-up (including brain and whole-
spine MRI and CSF cytology analysis), as 
complete a resection as possible, and 
postoperative craniospinal axia (CSA) 
irradiation.  
Nitrosourea-based chemotherapy is 
reserved for recurrent disease, as adjuvant 
chemotherapy has not shown significant 
benefit in adult medulloblastoma patients. 
Prospective studies are needed to 
accurately define significant prognostic factors 
and treatment regimens for adult patients with 
medulloblastomas. 
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